DCT

3:18-cv-14207

Valeant Pharma North America LLC v. Perrigo Pharma Intl DAC

General
Filed
09/21/18
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (02/25/19)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
67%